Why the study?
Does low molecular weight heparin plus aspirin improve live birth rates in women with recurrent pregnancy loss and autoantibodies or coagulation abnormalities compared to aspirin alone?
Does low molecular weight heparin plus aspirin improve live birth rates in women with recurrent pregnancy loss and autoantibodies or coagulation abnormalities compared to aspirin alone?
Low molecular weight heparin plus aspirin did not improve live birth rates compared to aspirin alone in women with recurrent pregnancy loss and autoantibodies or coagulation abnormalities.
No takes yet. Share an insight, caveat, or question.
Adding LMWH to ASA does not improve live births; challenges routine combination use and supports ASA monotherapy in this population.
Laskin et al. (2009) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: